| Stock |
Weight |
Amount |
| Bristol-myers Squibb Co. |
5.23% |
$26,816,054 |
| Amgen |
5.11% |
$26,202,426 |
| Johnson & Johnson |
4.94% |
$25,350,200 |
| Abbott Laboratories |
4.70% |
$24,104,806 |
| Merck & CO. |
4.68% |
$24,004,796 |
| Pfizer |
4.44% |
$22,801,659 |
| Lilly (eli) & Co. |
4.37% |
$22,398,090 |
| Santarus |
3.73% |
$19,158,319 |
| Actavis |
3.65% |
$18,707,376 |
| Warner Chilcott Plc-class A |
3.42% |
$17,569,932 |
| Biogen Idec |
3.26% |
$16,716,324 |
| Endo Health Solutions |
2.84% |
$14,554,721 |
| Salix Pharmaceuticals Ltd |
2.82% |
$14,490,577 |
| Hospira |
2.79% |
$14,291,631 |
| Questcor Pharmaceuticals |
2.77% |
$14,185,565 |
| Celgene |
2.76% |
$14,135,523 |
| Akorn |
2.68% |
$13,769,441 |
| Mylan |
2.55% |
$13,074,674 |
| Vivus |
2.55% |
$13,073,403 |
| Baxter International |
2.54% |
$13,043,908 |
| Page 1 2 next » |
|
